Association of Lipopolysaccharide-Toll-Like Receptor 4 Signaling and Microalbuminuria in Patients with Type 2 Diabetes Mellitus

References

• Stanton RC. Diabetic Kidney Disease and Hypertension. Exp Clin Endocrinology Diabetes. 2016;124(2):93–98. doi:10.1055/s-0035-1559760
   Web of Science ®Google Scholar
• Maqbool M, Cooper ME, Jandeleit-Dahm KAM. Cardiovascular Disease and Diabetic Kidney Disease. Semin Nephrol. 2018;38(3):217–232. doi:10.1016/j.semnephrol.2018.02.003
   PubMed Web of Science ®Google Scholar
• Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013;124(3):139–152. doi:10.1042/cs20120198
   PubMed Web of Science ®Google Scholar
• Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, García-Pérez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7(6):327–340. doi:10.1038/nrneph.2011.51
   PubMed Web of Science ®Google Scholar
• Patterson E, Ryan PM, Cryan JF, et al. Gut microbiota, obesity and diabetes. Postgrad Med J. 2016;92(1087):286–300. doi:10.1136/postgradmedj-2015-133285
   PubMed Web of Science ®Google Scholar
• Fava F, Gitau R, Griffin BA, Gibson GR, Tuohy KM, Lovegrove JA. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. Int J Obes. 2013;37(2):216–223. doi:10.1038/ijo.2012.33
   PubMed Web of Science ®Google Scholar
• Gomes AC, Bueno AA, de Souza RG, Mota JF. Gut microbiota, probiotics and diabetes. Nutr J. 2014;13:60. doi:10.1186/1475-2891-13-60
   PubMed Web of Science ®Google Scholar
• Chambers ES, Byrne CS, Morrison DJ, et al. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial. Gut. 2019;68(8):1430–1438. doi:10.1136/gutjnl-2019-318424
   PubMed Web of Science ®Google Scholar
• Sun YJ, Cao HJ, Song DD, Diao YG, Zhou J, Zhang TZ. Probiotics can alleviate cardiopulmonary bypass-induced intestinal mucosa damage in rats. Dig Dis Sci. 2013;58(6):1528–1536. doi:10.1007/s10620-012-2546-0
   Web of Science ®Google Scholar
• Sun XQ, Fu XB, Zhang R, et al. Relationship between plasma D(-)-lactate and intestinal damage after severe injuries in rats. World j Gastroenterol. 2001;7(4):555–558. doi:10.3748/wjg.v7.i4.555
   PubMed Web of Science ®Google Scholar
• Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000;12(1):20–26. doi:10.1016/s0952-7915(99)00046-1
   PubMed Web of Science ®Google Scholar
• Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol. 2005;3(1):36–46. doi:10.1038/nrmicro1068
   PubMed Web of Science ®Google Scholar
• Tran AX, Whitfield C. Lipopolysaccharides (Endotoxins). Encyclopedia of Microbiology. 3rd ed. Oxford: Academic Press; 2009:p:513–528.
   Google Scholar
• Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470–1481. doi:10.2337/db07-1403
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–1625. doi:10.2337/diabetes.54.6.1615
   PubMed Web of Science ®Google Scholar
• Sohail MU, Althani A, Anwar H, Rizzi R, Marei HE. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus. J Diabetes Res. 2017;2017:9631435. doi:10.1155/2017/9631435
   PubMed Web of Science ®Google Scholar
• Gomes JMG, Costa JA, Alfenas RCG. Metabolic endotoxemia and diabetes mellitus: a systematic review. Metabolism. 2017;68:133–144. doi:10.1016/j.metabol.2016.12.009
   PubMed Web of Science ®Google Scholar
• Nymark M, Pussinen PJ, Tuomainen AM, Forsblom C, Groop PH, Lehto M. Serum lipopolysaccharide activity is associated with the progression of kidney disease in finnish patients with type 1 diabetes. Diabetes Care. 2009;32(9):1689–1693. doi:10.2337/dc09-0467
   PubMed Web of Science ®Google Scholar
• Verzola D, Cappuccino L, D’Amato E, et al. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria. Kidney Int. 2014;86(6):1229–1243. doi:10.1038/ki.2014.116
   PubMed Web of Science ®Google Scholar
• Medicine IOC. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyper-Glycemia. Geneva World Health Organization; 2006.
   Google Scholar
• Patel S, Thompson AN. Screening, diagnosis, and management of type II diabetes: a review of the 2014 American Diabetes Association guidelines. Acta physiologica. 2014;4(3):107–113.
   Google Scholar
• Xu J, Liu Z, Zhan W, et al. Recombinant TsP53 modulates intestinal epithelial barrier integrity via upregulation of ZO‑1 in LPS‑induced septic mice. Mol Med Rep. 2018;17(1):1212–1218. doi:10.3892/mmr.2017.7946
   PubMed Web of Science ®Google Scholar
• Wu M, Xiao H, Ren W, et al. Therapeutic effects of glutamic acid in piglets challenged with deoxynivalenol. PLoS One. 2014;9(7):e100591. doi:10.1371/journal.pone.0100591
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Fava F, et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50(11):2374–2383. doi:10.1007/s00125-007-0791-0
   PubMed Web of Science ®Google Scholar
• Creely SJ, McTernan PG, Kusminski CM, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292(3):E740–747. doi:10.1152/ajpendo.00302.2006
   PubMed Web of Science ®Google Scholar
• Brar PC, Kohn B. Use of the microbiome in the management of children with type 2 diabetes mellitus. Curr Opin Pediatr. 2019;31(4):524–530. doi:10.1097/mop.0000000000000781
   Web of Science ®Google Scholar
• Evenepoel P, Poesen R, Meijers B. The gut-kidney axis. Pediatric Nephrol. 2017;32(11):2005–2014. doi:10.1007/s00467-016-3527-x
   PubMed Web of Science ®Google Scholar
• Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol. 2014;25(4):657–670. doi:10.1681/asn.2013080905
   PubMed Web of Science ®Google Scholar
• He X, Sun J, Liu C, et al. Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus. Diabetes Metab Syndr Obes. 2022;15:755–765. doi:10.2147/dmso.S347805
   PubMed Web of Science ®Google Scholar
• Kajiwara K, Takata S, To TT, et al. The promotion of nephropathy by Porphyromonas gingivalis lipopolysaccharide via toll-like receptors. Diabetol Metab Syndr. 2017;9:73. doi:10.1186/s13098-017-0271-8
   Web of Science ®Google Scholar
• Lassenius MI, Pietiläinen KH, Kaartinen K, et al. Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation. Diabetes Care. 2011;34(8):1809–1815. doi:10.2337/dc10-2197
   PubMed Web of Science ®Google Scholar
• Harte AL, Varma MC, Tripathi G, et al. High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects. Diabetes Care. 2012;35(2):375–382. doi:10.2337/dc11-1593
   PubMed Web of Science ®Google Scholar
• Zhou SY, Gillilland M, Wu X, et al. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J Clin Invest. 2018;128(1):267–280. doi:10.1172/jci92390
   PubMed Web of Science ®Google Scholar
• Yu WK, Li WQ, Li N, Li JS. Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. World j Gastroenterol. 2003;9(8):1824–1827. doi:10.3748/wjg.v9.i8.1824
   PubMed Web of Science ®Google Scholar
• Torres-Castro I, Arroyo-Camarena ÚD, Martínez-Reyes CP, et al. Human monocytes and macrophages undergo M1-type inflammatory polarization in response to high levels of glucose. Immunol Lett. 2016;176:81–89. doi:10.1016/j.imlet.2016.06.001
   PubMed Web of Science ®Google Scholar
• Wendel M, Paul R, Heller AR. Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med. 2007;33(1):25–35. doi:10.1007/s00134-006-0433-x
   PubMed Web of Science ®Google Scholar
• Anders HJ. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol. 2010;21(8):1270–1274. doi:10.1681/asn.2010030233
   PubMed Web of Science ®Google Scholar
• Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57(11):3090–3098. doi:10.2337/db08-0564
   PubMed Web of Science ®Google Scholar
• Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33(4):861–868. doi:10.2337/dc09-1799
   PubMed Web of Science ®Google Scholar
• Yang M, Gan H, Shen Q, Tang W, Du X, Chen D. Proinflammatory CD14+CD16+ monocytes are associated with microinflammation in patients with type 2 diabetes mellitus and diabetic nephropathy uremia. Inflammation. 2012;35(1):388–396. doi:10.1007/s10753-011-9374-9
   Web of Science ®Google Scholar
• Magnusson M, Magnusson KE, Sundqvist T, Denneberg T. Impaired intestinal barrier function measured by differently sized polyethylene glycols in patients with chronic renal failure. Gut. 1991;32(7):754–759. doi:10.1136/gut.32.7.754
   PubMed Web of Science ®Google Scholar
• Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19(3):433–442. doi:10.1681/asn.2007091048
   PubMed Web of Science ®Google Scholar
• Chuengsamarn S, Rattanamongkolgul S, Sittithumcharee G, Jirawatnotai S. Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes. Diabetes Metab Syndr. 2017;11(2):103–108. doi:10.1016/j.dsx.2016.08.012
   Web of Science ®Google Scholar
• Zhao T, Zhang H, Yin X, et al. Tangshen formula modulates gut Microbiota and reduces gut-derived toxins in diabetic nephropathy rats. Biomed Pharmacother. 2020;129:110325. doi:10.1016/j.biopha.2020.110325
   PubMed Web of Science ®Google Scholar
• Jialal I, Major AM, Devaraj S. Global Toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy. J Diabetes Complications. 2014;28(6):755–761. doi:10.1016/j.jdiacomp.2014.07.003
   Web of Science ®Google Scholar
• Garibotto G, Carta A, Picciotto D, Viazzi F, Verzola D. Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy. J Nephrol. 2017;30(6):719–727. doi:10.1007/s40620-017-0432-8
   PubMed Web of Science ®Google Scholar
• Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Curr Diab Rep. 2017;17(3):16. doi:10.1007/s11892-017-0841-z
   PubMed Web of Science ®Google Scholar
• He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017;7:54. doi:10.1186/s13578-017-0183-1
   Web of Science ®Google Scholar